In a patient with a urine culture showing less than 10,000 CFU/mL Candida albicans, what is the appropriate management?

Management of Low-Level Candiduria (<10,000 CFU/mL)

In most cases, do NOT treat candiduria with less than 10,000 CFU/mL of Candida albicans—this typically represents colonization rather than infection and antifungal therapy is not indicated unless the patient belongs to a high-risk group. 1

Primary Management Approach

The cornerstone of management is elimination of predisposing factors, not antifungal therapy:

• Remove indwelling bladder catheters immediately if feasible (this is the single most important intervention) 1
• Discontinue or modify unnecessary antibiotics
• Address any urinary tract obstruction

Key principle: Colony counts, especially with catheter in place, cannot reliably differentiate infection from colonization 1. Even pyuria does not distinguish between the two 1.

When to Treat (High-Risk Groups Only)

Antifungal therapy is NOT recommended except in these specific high-risk populations 1:

1. Neutropenic patients

• Treat as candidemia (not as isolated UTI)
• Use fluconazole 400-800 mg (6-12 mg/kg) daily OR echinocandin 1

2. Very low-birth-weight infants (<1500g)

• Treat as disseminated candidiasis
• Use amphotericin B deoxycholate 1 mg/kg daily OR fluconazole 12 mg/kg daily 1

3. Patients undergoing urologic procedures

• Prophylactic treatment for several days before and after procedure
• Oral fluconazole 400 mg (6 mg/kg) daily OR amphotericin B deoxycholate 0.3-0.6 mg/kg daily 1

If Symptomatic Cystitis is Present

For the rare patient with true symptomatic lower urinary tract infection (dysuria, frequency, urgency) AND candiduria:

• For fluconazole-susceptible C. albicans: Oral fluconazole 200 mg (3 mg/kg) daily for 2 weeks 1
• Remove catheter if present (strongly recommended) 1

Common Pitfalls to Avoid

Critical mistake: Studies show 60-75% of clinicians inappropriately treat candiduria that represents colonization 2, 3. This leads to:

• Unnecessary antifungal exposure
• Increased costs
• Potential selection for resistant organisms
• No improvement in outcomes 4

Important caveat: Treatment does not influence microbiologic outcomes in asymptomatic candiduria—the funguria persists whether treated or not 4. Removing predisposing factors clears candiduria in approximately 50% of cases without antifungals 5.

What NOT to Do

• Do not treat based on a single positive culture without confirming infection 2
• Do not use echinocandins or other azoles besides fluconazole—they achieve inadequate urine concentrations 1, 5
• Do not use lipid formulations of amphotericin B for UTI—they do not achieve adequate urine levels 1
• Do not perform bladder irrigation in routine cases (reserved only for fluconazole-resistant species like C. glabrata/krusei) 1

Clinical Decision Algorithm

1. Confirm candiduria is real (not contamination)
2. Assess patient risk category: neutropenic? neonate <1500g? planned urologic procedure?
3. If NOT high-risk: Remove catheter, stop antibiotics → observe
4. If high-risk: Treat according to specific category above
5. If symptomatic cystitis: Confirm symptoms are truly from UTI (not catheter irritation), then treat with fluconazole

The evidence consistently demonstrates that the vast majority of candiduria represents benign colonization that resolves with catheter removal alone, and unnecessary antifungal treatment provides no benefit while exposing patients to potential harm 1, 4.